Total Payments
$1.2M
2024 Payments
$266,201
Companies
21
Transactions
2,607
Payment Breakdown by Category
Other$755,555 (61.1%)
Consulting$218,782 (17.7%)
Travel$218,632 (17.7%)
Food & Beverage$43,732 (3.5%)
Education$338.02 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $755,555 | 361 | 61.1% |
| Consulting Fee | $218,782 | 98 | 17.7% |
| Travel and Lodging | $218,632 | 1,015 | 17.7% |
| Food and Beverage | $43,732 | 1,125 | 3.5% |
| Education | $338.02 | 8 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $287,687 | 642 | $0 (2021) |
| Axsome Therapeutics, Inc. | $243,118 | 368 | $0 (2024) |
| ABBVIE INC. | $159,447 | 288 | $0 (2024) |
| Allergan, Inc. | $141,567 | 498 | $0 (2020) |
| ITI, Inc. | $134,838 | 187 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $78,271 | 156 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $70,639 | 166 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $51,204 | 76 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $31,936 | 46 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $22,483 | 79 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $266,201 | 409 | Axsome Therapeutics, Inc. ($127,998) |
| 2023 | $288,855 | 469 | Axsome Therapeutics, Inc. ($115,045) |
| 2022 | $118,979 | 191 | ITI, Inc. ($68,149) |
| 2021 | $55,622 | 119 | ITI, Inc. ($19,610) |
| 2020 | $87,201 | 236 | Allergan, Inc. ($51,002) |
| 2019 | $161,014 | 534 | Allergan Inc. ($75,611) |
| 2018 | $151,195 | 362 | Sunovion Pharmaceuticals Inc. ($101,581) |
| 2017 | $107,972 | 287 | Sunovion Pharmaceuticals Inc. ($96,457) |
All Payment Transactions
2,607 individual payment records from CMS Open Payments — Page 1 of 105
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.13 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,040.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,106.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Travel and Lodging | In-kind items and services | $1,189.38 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Travel and Lodging | In-kind items and services | $246.25 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $167.74 | General |
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $130.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $87.69 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $64.79 | General |
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $48.31 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $31.68 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/12/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/12/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/12/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Travel and Lodging | Cash or cash equivalent | $834.15 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/12/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Travel and Lodging | Cash or cash equivalent | $369.15 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/12/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Travel and Lodging | Cash or cash equivalent | $174.55 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/12/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $94.06 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/12/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/12/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $6.75 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $109.63 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $9.82 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $8.68 | General |
| Category: Psychiatry/Psychology | ||||||
About Dr. Bibi Das, MD
Dr. Bibi Das, MD is a Psychiatry healthcare provider based in Stanford, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528012374.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bibi Das, MD has received a total of $1.2M in payments from pharmaceutical and medical device companies, with $266,201 received in 2024. These payments were reported across 2,607 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($755,555).
Ad
Practice Information
- Specialty Psychiatry
- Location Stanford, CA
- Active Since 05/19/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1528012374
Products in Payments
- VRAYLAR (Drug) $299,847
- LATUDA (Drug) $287,645
- Auvelity (Drug) $243,091
- CAPLYTA (Drug) $166,774
- REXULTI (Drug) $71,326
- AUSTEDO (Drug) $58,636
- INGREZZA (Drug) $51,204
- Trintellix (Drug) $22,181
- UZEDY (Drug) $18,539
- FANAPT (Drug) $11,036
- SD809-TD (Drug) $763.36
- TRINTELLIX (Drug) $516.50
- VIIBRYD (Drug) $248.85
- ABILIFY MAINTENA (Drug) $215.89
- Fanapt (Drug) $129.99
- Austedo XR (Drug) $110.84
- VYVANSE (Drug) $104.66
- Adlarity (Drug) $76.75
- Leqembi (Drug) $54.56
- ARISTADA (Drug) $46.90
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Stanford
Alan Schatzberg, Md, MD
Psychiatry — Payments: $250,142
Psychiatry $250,142
Ira Glick
Psychiatry — Payments: $68,630
Psychiatry $68,630
Patricia Suppes, Md Phd, MD PHD
Psychiatry — Payments: $23,509
Psychiatry $23,509
Natalia Rasgon, Md, MD
Psychiatry — Payments: $17,472
Psychiatry $17,472
Carolyn Rodriguez, Md, Phd, MD, PHD
Psychiatry — Payments: $12,773
Psychiatry $12,773
Douglas Noordsy, Md, MD
Psychiatry — Payments: $6,799
Psychiatry $6,799